SlideShare una empresa de Scribd logo
1 de 16
Descargar para leer sin conexión
SHOCK

PREPARED BY DR.KUCHA
shock
• tissue hypoperfusion that is insufficient to maintain normal aerobic
metabolism
       • consists of inadequate tissue perfusion marked by decreased
       delivery of required metabolic substrates and inadequate removal of
       cellular waste products


• the resultant cellular injury is initially reversible; if the hypoperfusion is
severe enough and prolonged, the cellular injury becomes irriversible


• the clinical manifestations are the result of:
       •stimulation of the sympathetic and neuro-endocrine stress responses
       • inadequate oxygen delivery
       • end-organ dysfunction
patho-physiology of shock


 disruption host-microbial
                                                         trauma
        equilibrium



                              tissue hypoperfusion




 neurologic injury
                             cellular hypoxia/ischemia




                                                         hemorrhage
  acute heart failure


                                      shock
neuro-endocrine response to hemorrhage
 • its goal is to maintain perfusion to the heart and brain , even at the expense of other organ systems
 • mechanisms include:
         • autonomic control of peripheral vascular tone and cardiac contractility
         • hormonal response to stress and volume depletion
         • local microcirculatory mechanisms that are organ specific and regulate regional blood flow

afferent signals
• loss of circulating blood volume
• pain, hypoxemia, hypercarbia, acidosis,
infection, changes in temperature,
emotional arousalm, hypoglycemia
• baroreceptors
        • within the atria of the heart which                                              efferent signals
        are sensitive to changes in chambert-                                              • cardio-vascular response
        pressure and wall stretch                                                          • hormonal response
        • aortic arch and carotid bodies                                                   • circulatory homeostasis
• chemoreceptors in the aorta and carotid                                                  • microcirculatory respons
bodies are sensitive to changes in O2
tension, H+ ion concentration, and carbon
dioxide (CO2) levels
        • stimulation of the chemoreceptors
        results in vasodilation of the
        coronary arteries, slowing of the
        heart rate, and vasoconstriction of
        the splanchnic and skeletal
        circulation
• a variety of protein and nonprotein
mediators are produced at the site of injury
as part of the inflammatory response, and
they act as afferent impulses to induce a
host response
cardio-vascular response
• hemorrhage results in diminished venous return to the heart and
decreased cardiac output

      • stimulation of sympathetic fibers innervating the heart
      leads to activation of beta1-adrenergic receptors that
      increase heart rate and contractility

      • sympathetic stimulation of the peripheral circulation via
      the activation of alpha1-adrenergic receptors on arterioles
      induces vasoconstriction and causes a compensatory
      increase in systemic vascular resistance and blood pressure

      • sympathetic stimulation also induces constriction of
      venous vessels, decreasing the capacitance of the circulatory
      system and accelerating blood return to the central
      circulation
hormonal response

• shock       hypothalamus (CRH)         pituitary gland (ACTH)      adrenal cortex (cortisol)
      • cortisol stimulates gluconeogenesis and insulin resistance, resulting in hyperglycemia
      • cortisol stimulates muscle cell protein breakdown and lipolysis to provide substrates
      for hepatic gluconeogenesis
      • cortisol causes retention of sodium and water by the nephrons of the kidneys

• renin-angiotensin system is activated in shock
       • decreased renal artery perfusion, beta-adrenergic stimulation, and increased renal
       tubular sodium concentration cause the release of renin from the juxtaglomerular cells

   • decreased renal    •release of renin      • renin catalyzes the    • angiotensin I has no significant functional
   artery perfusion     from the               conversion of            activity
   • beta-adrenergic    juxtaglomerular        angiotensinogen          • angiotensin II
   stimulation          cells                  (produced by the                  • a potent vasoconstrictor of both
   • increased renal                           liver) to angiotensin             splanchnic and peripheral vascular
   tubular sodium                              I, which is then                  beds
   concentration                               converted to                      • stimulates the secretion of
   cause the release                           angiotensin II by                 aldosterone, ACTH, and antidiuretic
   of renin from the                           angiotensin-                      hormone (ADH)
   juxtaglomerular                             converting enzyme                         • aldosterone acts on the
   cells                                       (ACE) produced in                         nephron to promote
                                               the lung                                  reabsorption of sodium water.
                                                                                                 • potassium and
                                                                                                 hydrogen ions are lost
                                                                                                 in the urine in exchange
                                                                                                 for sodium.
• epinephrine
• hypovolemia                                                                   • angiotensin II
                                                                                • pain
• changes in circulating                                                        • hyperglycemia
blood volume sensed by
baroreceptors and left         • pituitary gland releases                          increase the
atrial stretch receptors       vasopressin or ADH                                 release of ADH

• increased plasma
osmolality detected by
hypothalamic
osmoreceptors

                           • ADH acts:

                                  • on the distal tubule and collecting duct of the nephron to
                                  increase water permeability, decrease water and sodium
                                  losses, and preserve intravascular volume

                                  • as a potent mesenteric vasoconstrictor, shunting circulating
                                  blood away from the splanchnic organs during hypovolemia
                                          • this may contribute to intestinal ischemia and
                                          predispose to intestinal mucosal barrier dysfunction in
                                          shock states

                                  • increases hepatic gluconeogenesis and increases hepatic
                                  glycolysis
Microcirculation
• the microvascular bed is innervated by the sympathetic nervous system and has a profound effect on the larger
arterioles
                                                                     • other vasoactive proteins including:
            • following hemorrhage                                           • vasopressin
            larger arterioles                                                • angiotensin II
            vasoconstrict; small                                             • endothelin-1
            distal arterioles
            vasodilate                                                      • also lead to vasoconstriction to limit
                                                                            organ perfusion to organs such as skin,
                                                                            skeletal muscle, kidneys, and the GI
                                                                            tract to preserve perfusion of the
                                                                            myocardium and CNS
            • flow in the capillary bed often is heterogeneous
            in shock states, which likely is secondary to
            multiple local mechanisms, including endothelial
            cell swelling, dysfunction, and activation marked
            by the recruitment of leukocytes



            • failure of the integrity of         • decreased capillary hydrostatic
            the endothelium of the                pressure secondary to changes in
            microcirculation and                  blood flow and increased cellular
            development of capillary              uptake of fluid
            leak, intracellular swelling,
            and the development of
            an extracellular fluid
            deficit                              • intracellular swelling is multifactorial, but
                                                 dysfunction of energy-dependent mechanisms,
                                                 such as active transport by the sodium-potassium
                                                 pump contributes to loss of membrane integrity.
metabolic effects
 • cellular metabolism is based primarily on the hydrolysis of adenosine triphosphate (ATP)
 • majority of ATP is generated in our bodies through aerobic metabolism in the process of
 oxidative phosphorylation in the mitochondria
          • dependent on the availability of O2 as a final electron acceptor in the electron
          transport chain
                                                                           • when oxidative phosphorylation is insufficient, the
                                                                           cells shift to anaerobic metabolism and glycolysis to
 • O2 tension within a cell decreases,                                     generate ATP
 there is a decrease in oxidative                                                  • this occurs via the breakdown of cellular
 phosphorylation, and the                                                          glycogen stores to pyruvate
 generation of ATP slows
                                                                           • under hypoxic conditions in anaerobic metabolism,
                                                                           pyruvate is converted into lactate, leading to an
                                                                           intracellular metabolic acidosis



  • depletion of ATP potentially
  influences all ATP-dependent
  cellular processes:
                                                • decreased intracellular pH also influences vital cellular functions such as:
          • maintenance of cellular
                                                       • normal enzyme activity
          membrane potential
                                                       • cell membrane ion exchange
          • synthesis of enzymes and
                                                       • cellular metabolic signaling
          proteins
                                                       • acidosis leads to changes in calcium metabolism and calcium
          • cell signaling
                                                       signaling
          • DNA repair mechanisms
immune and inflammatory responses

• a well regulated complex set of interactions between
circulating soluble factors and cells that can arise in
response to trauma, infection, ischemia, toxic, or
autoimmune stimuli

• direct tissue injury or infection

• activation of the active inflammatory    • intracellular products from damaged and       • pattern recognition receptors (PRRs) - cell surface
and immune responses by the release of     injured cells can have paracrine and                     • Toll-like receptors (TLRs)
bioactive peptides by neurons in           endocrine-like effects on distant tissues to             • receptor for advanced glycation end
response to pain and the release of        activate the inflammatory and immune                     products
intracellular molecules by broken          responses       –     DANGER        SIGNALING
cells,     such    as     heat    shock    HYPOTHESIS                                              • initiation of the repair process and the
proteins,                  mitochondrial            • endogenous molecules (damage                 mobilization of antimicrobial defenses at the
peptides, heparan sulfate, high mobility            associated molecular patterns                  site of tissue disruption
group box 1, and RNA                                {DAMP}) are capable of signaling               • leads to intracellular signaling and release of
                                                    the presence of danger to                      cellular products including cytokines
                                                    surrounding cells and tissues
                                                    • DAMP:
                                                                                           • tissue-based macrophages or mast cells act as
                                                             • Hyaluronan oligomers
                                                                                           sentinel responders, releasing histamines,
                                                             • Heparan sulfate
                                                                                           eicosanoids, tryptases, and cytokines
                                                             • Extra domain A of
                                                             fibronectin
                                                             • Heat shock proteins 60,
                                                             70,
                                                             • Gp96
                                                             •Surfactant Protein A -
                                                             Defensin 2
                                                             • Fibrinogen
                                                             • Biglycan
                                                             • High mobility group box 1
                                                             • Uric acid
                                                             • Interleukin-1 S-100s
                                                             Nucleolin
Hypovolemic/Hemorrhagic Shock

• most common cause of shock in the surgical or
trauma patient is loss of circulating volume from
hemorrhage



 • acute blood loss



        • decreased baroreceptor                • decreased inhibition of
        stimulation from stretch                vasoconstrictor centers in the brain
        receptors in the large arteries         stem, increased chemoreceptor
                                                stimulation of vasomotor centers,
                                                and diminished output from atrial        • increase vasoconstriction
                                                stretch receptors                        and peripheral arterial
                                                                                         resistance



                                                    • epinephrine and norepinephrine
        • induces sympathetic stimulation
                                                    release, activation of the renin-
                                                    angiotensin cascade, and increased
                                                    vasopressin release
Classification of Hemorrhage
                  Class
Parameter         I            II               III               IV
Blood loss (mL)   <750         750–1500         1500–2000         >2000
Blood loss (%)    <15          15–30            30–40             >40
Heart rate (bpm) <100          >100             >120              >140
Blood pressure    Normal       Orthostatic      Hypotension        Severe
                                                                   hypotension
CNS symptoms      Normal       anxious          confused           obtunded,
                               mild tachycardia hypotension,       immediately life
                               tachypnea        marked             threatening, and
                                                tachycardia [i.e., generally
                                                pulse greater      requires
                                                than 110 to 120 operative
                                                beats per          control of
                                                minute (bpm)] bleeding
• the appropriate priorities in patients with hemorrhagic shock are:
        • secure the airway
        • control the source of blood loss
        • IV volume resuscitation

• patients who fail to respond to initial resuscitative efforts should be assumed to have ongoing active hemorrhage from large
vessels and require prompt operative intervention
        • diagnostic and therapeutic laparotomy or thoracotomy

• patients who respond to initial resuscitative effort but then deteriorate hemodynamically frequently have injuries that require
operative intervention

• patients who fail to respond to resuscitative efforts despite adequate control of ongoing hemorrhage
        • have ongoing fluid requirements despite adequate control of hemorrhage
        • have persistent hypotension despite restoration of intravascular volume necessitating vasopressor support
        • exhibit a futile cycle of uncorrectable hypothermia, hypoperfusion, acidosis, and coagulopathy that cannot be interrupted
        despite maximum therapy

       • these patients have deteriorated to decompensated or irreversible shock with peripheral vasodilation and resistance to
       vasopressor infusion
       • mortality is inevitable once the patient manifests shock in its terminal stages

• transfusion of packed red blood cells and other blood products is essential in the treatment of patients in hemorrhagic shock
        • current recommendations in stable ICU patients aim for a target hemoglobin of 7 to 9 g/dL

       • fresh frozen plasma (FFP) should also be transfused in patients with massive bleeding or bleeding with increases in
       prothrombin or activated partial thromboplastin times 1.5 times greater than control

• additional resuscitative adjuncts in patients with hemorrhagic shock include minimization of heat loss and maintaining
normothermia
        • development of hypothermia in the bleeding patient is associated with acidosis, hypotension, and coagulopathy
        • hypothermia in bleeding trauma patients is an independent risk factor for bleeding and death
Septic Shock (Vasodilatory Shock)

• vasodilatory shock is the result of dysfunction of the endothelium and vasculature secondary to circulating
inflammatory mediators and cells or as a response to prolonged and severe hypoperfusion
      • hypotension results from failure of the vascular smooth muscle to constrict appropriately

• characterized by peripheral vasodilation with resultant hypotension and resistance to treatment with
vasopressors

• the most frequently encountered form of vasodilatory shock is septic shock
       • other causes include:
             • hypoxic lactic acidosis
             • carbon monoxide poisoning
             • decompensated and irreversible hemorrhagic shock
             • terminal cardiogenic shock
             • postcardiotomy shock

             • vasodilatory shock seems to represent the final common pathway for profound and prolonged
             shock of any etiology

• in addition to fever, tachycardia, and tachypnea, signs of hypoperfusion such as confusion, malaise, oliguria, or
hypotension may be present
       • these should prompt an aggressive search for infection, including a thorough physical examination,
       inspection of all wounds, evaluation of intravascular catheters or other foreign bodies, obtaining
       appropriate cultures, and adjunctive imaging studies, as needed
• evaluation of the patient in septic shock begins with an assessment of the adequacy of their airway and
ventilation
       • severely obtunded patients and patients whose work of breathing is excessive require intubation and
       ventilation to prevent respiratory collapse

• vasodilation and decrease in total peripheral resistance may produce hypotension
      • fluid resuscitation and restoration of circulatory volume with balanced salt solutions is essential

• empiric antibiotics must be chosen carefully based on the most likely pathogens (gram-negative rods, gram-
positive cocci, and anaerobes) because the portal of entry of the offending organism and its identity may not be
evident until culture data return or imaging studies are completed
       • knowledge of the bacteriologic profile of infections in an individual unit can be obtained from most
       hospital infection control departments and will suggest potential responsible organisms

      • antibiotics should be tailored to cover the responsible organisms once culture data are available, and if
      appropriate, the spectrum of coverage narrowed

• after first-line therapy of the septic patient with antibiotics, IV fluids, and intubation if necessary, vasopressors
may be necessary to treat patients with septic shock
       • catecholamines are the vasopressors used most often

• hyperglycemia and insulin resistance are typical in critically ill and septic patients, including patients without
underlying diabetes mellitus

Más contenido relacionado

La actualidad más candente (19)

Seminar On Shock By Dr Abdul Qahar Qureshi
Seminar On Shock By Dr Abdul Qahar Qureshi Seminar On Shock By Dr Abdul Qahar Qureshi
Seminar On Shock By Dr Abdul Qahar Qureshi
 
Shock
Shock	Shock
Shock
 
Management of Shock
Management of Shock Management of Shock
Management of Shock
 
Shock and its management
Shock  and its managementShock  and its management
Shock and its management
 
Shock & blood transfusion
Shock & blood transfusionShock & blood transfusion
Shock & blood transfusion
 
Types and treatment of shock
Types and treatment of shockTypes and treatment of shock
Types and treatment of shock
 
The physiology of shock
The physiology of shock  The physiology of shock
The physiology of shock
 
Physiology of shock
Physiology  of shockPhysiology  of shock
Physiology of shock
 
Shock
ShockShock
Shock
 
SHOCK
SHOCKSHOCK
SHOCK
 
Classification of shock
Classification of shockClassification of shock
Classification of shock
 
Shock
ShockShock
Shock
 
Shock
Shock Shock
Shock
 
Shock and types of shock
Shock and types of shockShock and types of shock
Shock and types of shock
 
shock seminar
shock seminar shock seminar
shock seminar
 
Shock
ShockShock
Shock
 
Shock
ShockShock
Shock
 
Shock for BS Medical technologist
Shock for BS Medical technologistShock for BS Medical technologist
Shock for BS Medical technologist
 
Shock
Shock Shock
Shock
 

Similar a Shock

Circulatory disorders
Circulatory disordersCirculatory disorders
Circulatory disordersRASHA
 
ANTIDIURETIC HORMONE pptx
ANTIDIURETIC HORMONE pptxANTIDIURETIC HORMONE pptx
ANTIDIURETIC HORMONE pptxÖmer aslankan
 
Edema pathogenesis,causes, approach.pptx
Edema pathogenesis,causes, approach.pptxEdema pathogenesis,causes, approach.pptx
Edema pathogenesis,causes, approach.pptxAnujaJacob5
 
Renalfailure 090305183548-phpapp01
Renalfailure 090305183548-phpapp01Renalfailure 090305183548-phpapp01
Renalfailure 090305183548-phpapp01052572
 
Fluid &electrolyte balance
Fluid &electrolyte balanceFluid &electrolyte balance
Fluid &electrolyte balancesuchismita sethi
 
cardiac physiology
cardiac physiologycardiac physiology
cardiac physiologyHETA PATEL
 
1011shock-161227090739.pdf
1011shock-161227090739.pdf1011shock-161227090739.pdf
1011shock-161227090739.pdfAditya Raghav
 
CONTROL OF ARTERIAL BLOOD PRESSURE.pptx
CONTROL OF ARTERIAL BLOOD PRESSURE.pptxCONTROL OF ARTERIAL BLOOD PRESSURE.pptx
CONTROL OF ARTERIAL BLOOD PRESSURE.pptxMazinTarigAljazz
 
=2343 Lecture 6 Adrenal Gland DISORDER .pptx
=2343 Lecture 6 Adrenal Gland DISORDER .pptx=2343 Lecture 6 Adrenal Gland DISORDER .pptx
=2343 Lecture 6 Adrenal Gland DISORDER .pptxsamirich1
 
Shock (intensive course 1st year Mmed).pptx
Shock (intensive course 1st year Mmed).pptxShock (intensive course 1st year Mmed).pptx
Shock (intensive course 1st year Mmed).pptxssuser2b0ef3
 

Similar a Shock (20)

SHOCK.pptx
SHOCK.pptxSHOCK.pptx
SHOCK.pptx
 
SHOCK.pptx
SHOCK.pptxSHOCK.pptx
SHOCK.pptx
 
Circulatory disorders
Circulatory disordersCirculatory disorders
Circulatory disorders
 
ANTIDIURETIC HORMONE pptx
ANTIDIURETIC HORMONE pptxANTIDIURETIC HORMONE pptx
ANTIDIURETIC HORMONE pptx
 
Edema pathogenesis,causes, approach.pptx
Edema pathogenesis,causes, approach.pptxEdema pathogenesis,causes, approach.pptx
Edema pathogenesis,causes, approach.pptx
 
Renalfailure 090305183548-phpapp01
Renalfailure 090305183548-phpapp01Renalfailure 090305183548-phpapp01
Renalfailure 090305183548-phpapp01
 
Shock
ShockShock
Shock
 
Fluid &electrolyte balance
Fluid &electrolyte balanceFluid &electrolyte balance
Fluid &electrolyte balance
 
Progressive Shock
Progressive ShockProgressive Shock
Progressive Shock
 
Hemorhage & shock
Hemorhage & shockHemorhage & shock
Hemorhage & shock
 
cardiac physiology
cardiac physiologycardiac physiology
cardiac physiology
 
10 &amp;11 shock
10 &amp;11 shock10 &amp;11 shock
10 &amp;11 shock
 
1011shock-161227090739.pdf
1011shock-161227090739.pdf1011shock-161227090739.pdf
1011shock-161227090739.pdf
 
Types of Shock
Types of Shock Types of Shock
Types of Shock
 
Pathophysiology of shock
Pathophysiology of shockPathophysiology of shock
Pathophysiology of shock
 
Renal function test
Renal function testRenal function test
Renal function test
 
CONTROL OF ARTERIAL BLOOD PRESSURE.pptx
CONTROL OF ARTERIAL BLOOD PRESSURE.pptxCONTROL OF ARTERIAL BLOOD PRESSURE.pptx
CONTROL OF ARTERIAL BLOOD PRESSURE.pptx
 
=2343 Lecture 6 Adrenal Gland DISORDER .pptx
=2343 Lecture 6 Adrenal Gland DISORDER .pptx=2343 Lecture 6 Adrenal Gland DISORDER .pptx
=2343 Lecture 6 Adrenal Gland DISORDER .pptx
 
SHOCK .pptx
SHOCK .pptxSHOCK .pptx
SHOCK .pptx
 
Shock (intensive course 1st year Mmed).pptx
Shock (intensive course 1st year Mmed).pptxShock (intensive course 1st year Mmed).pptx
Shock (intensive course 1st year Mmed).pptx
 

Más de Nilesh Kucha

Chapter 39 role of radiotherapy in benign diseases.pptx [read only]
Chapter 39 role of radiotherapy in benign diseases.pptx [read only]Chapter 39 role of radiotherapy in benign diseases.pptx [read only]
Chapter 39 role of radiotherapy in benign diseases.pptx [read only]Nilesh Kucha
 
Chapter 39 role of radiotherapy in benign diseases
Chapter 39 role of radiotherapy in benign diseasesChapter 39 role of radiotherapy in benign diseases
Chapter 39 role of radiotherapy in benign diseasesNilesh Kucha
 
Chapter 39 role of radiotherapy in benign diseases
Chapter 39 role of radiotherapy in benign diseasesChapter 39 role of radiotherapy in benign diseases
Chapter 39 role of radiotherapy in benign diseasesNilesh Kucha
 
Chapter 38 role of surgery in cancer prevention
Chapter 38 role of surgery in cancer preventionChapter 38 role of surgery in cancer prevention
Chapter 38 role of surgery in cancer preventionNilesh Kucha
 
Chapter 36 t reg cells
Chapter 36 t reg cellsChapter 36 t reg cells
Chapter 36 t reg cellsNilesh Kucha
 
Chapter 35 tumor lysis syndrome
Chapter 35 tumor lysis syndromeChapter 35 tumor lysis syndrome
Chapter 35 tumor lysis syndromeNilesh Kucha
 
Chapter 34 medical stat
Chapter 34 medical statChapter 34 medical stat
Chapter 34 medical statNilesh Kucha
 
Chapter 33 isolated tumor cells
Chapter 33 isolated tumor cellsChapter 33 isolated tumor cells
Chapter 33 isolated tumor cellsNilesh Kucha
 
Chapter 32 invasion and metastasis
Chapter 32 invasion and metastasisChapter 32 invasion and metastasis
Chapter 32 invasion and metastasisNilesh Kucha
 
Chapter 31 genetic counselling
Chapter 31 genetic counsellingChapter 31 genetic counselling
Chapter 31 genetic counsellingNilesh Kucha
 
Chapter 30 febrile neutropenia
Chapter 30 febrile neutropeniaChapter 30 febrile neutropenia
Chapter 30 febrile neutropeniaNilesh Kucha
 
Chapter 29 dendritic cells
Chapter 29 dendritic cellsChapter 29 dendritic cells
Chapter 29 dendritic cellsNilesh Kucha
 
Chapter 28 clincal trials
Chapter 28 clincal trials Chapter 28 clincal trials
Chapter 28 clincal trials Nilesh Kucha
 
Chapter 27 chemotherapy side effects dr lms
Chapter 27 chemotherapy side effects  dr lmsChapter 27 chemotherapy side effects  dr lms
Chapter 27 chemotherapy side effects dr lmsNilesh Kucha
 
Chapter 26 chemoprevention of cancer
Chapter 26 chemoprevention of cancerChapter 26 chemoprevention of cancer
Chapter 26 chemoprevention of cancerNilesh Kucha
 
Chapter 25 assessment of clincal responses
Chapter 25 assessment of clincal responsesChapter 25 assessment of clincal responses
Chapter 25 assessment of clincal responsesNilesh Kucha
 
Chapter 24.3 metronomic chemotherapy
Chapter 24.3 metronomic chemotherapyChapter 24.3 metronomic chemotherapy
Chapter 24.3 metronomic chemotherapyNilesh Kucha
 
Chapter 24.2 lmwh in cancer asso thrombosis
Chapter 24.2 lmwh in cancer asso thrombosisChapter 24.2 lmwh in cancer asso thrombosis
Chapter 24.2 lmwh in cancer asso thrombosisNilesh Kucha
 
Chapter 24.1 kinase inhibitors and monoclonal antibodies
Chapter 24.1 kinase inhibitors and monoclonal antibodiesChapter 24.1 kinase inhibitors and monoclonal antibodies
Chapter 24.1 kinase inhibitors and monoclonal antibodiesNilesh Kucha
 

Más de Nilesh Kucha (20)

Chapter 39 role of radiotherapy in benign diseases.pptx [read only]
Chapter 39 role of radiotherapy in benign diseases.pptx [read only]Chapter 39 role of radiotherapy in benign diseases.pptx [read only]
Chapter 39 role of radiotherapy in benign diseases.pptx [read only]
 
Chapter 39 role of radiotherapy in benign diseases
Chapter 39 role of radiotherapy in benign diseasesChapter 39 role of radiotherapy in benign diseases
Chapter 39 role of radiotherapy in benign diseases
 
Chapter 39 role of radiotherapy in benign diseases
Chapter 39 role of radiotherapy in benign diseasesChapter 39 role of radiotherapy in benign diseases
Chapter 39 role of radiotherapy in benign diseases
 
Chapter 38 role of surgery in cancer prevention
Chapter 38 role of surgery in cancer preventionChapter 38 role of surgery in cancer prevention
Chapter 38 role of surgery in cancer prevention
 
Chapter 37 svco
Chapter 37 svcoChapter 37 svco
Chapter 37 svco
 
Chapter 36 t reg cells
Chapter 36 t reg cellsChapter 36 t reg cells
Chapter 36 t reg cells
 
Chapter 35 tumor lysis syndrome
Chapter 35 tumor lysis syndromeChapter 35 tumor lysis syndrome
Chapter 35 tumor lysis syndrome
 
Chapter 34 medical stat
Chapter 34 medical statChapter 34 medical stat
Chapter 34 medical stat
 
Chapter 33 isolated tumor cells
Chapter 33 isolated tumor cellsChapter 33 isolated tumor cells
Chapter 33 isolated tumor cells
 
Chapter 32 invasion and metastasis
Chapter 32 invasion and metastasisChapter 32 invasion and metastasis
Chapter 32 invasion and metastasis
 
Chapter 31 genetic counselling
Chapter 31 genetic counsellingChapter 31 genetic counselling
Chapter 31 genetic counselling
 
Chapter 30 febrile neutropenia
Chapter 30 febrile neutropeniaChapter 30 febrile neutropenia
Chapter 30 febrile neutropenia
 
Chapter 29 dendritic cells
Chapter 29 dendritic cellsChapter 29 dendritic cells
Chapter 29 dendritic cells
 
Chapter 28 clincal trials
Chapter 28 clincal trials Chapter 28 clincal trials
Chapter 28 clincal trials
 
Chapter 27 chemotherapy side effects dr lms
Chapter 27 chemotherapy side effects  dr lmsChapter 27 chemotherapy side effects  dr lms
Chapter 27 chemotherapy side effects dr lms
 
Chapter 26 chemoprevention of cancer
Chapter 26 chemoprevention of cancerChapter 26 chemoprevention of cancer
Chapter 26 chemoprevention of cancer
 
Chapter 25 assessment of clincal responses
Chapter 25 assessment of clincal responsesChapter 25 assessment of clincal responses
Chapter 25 assessment of clincal responses
 
Chapter 24.3 metronomic chemotherapy
Chapter 24.3 metronomic chemotherapyChapter 24.3 metronomic chemotherapy
Chapter 24.3 metronomic chemotherapy
 
Chapter 24.2 lmwh in cancer asso thrombosis
Chapter 24.2 lmwh in cancer asso thrombosisChapter 24.2 lmwh in cancer asso thrombosis
Chapter 24.2 lmwh in cancer asso thrombosis
 
Chapter 24.1 kinase inhibitors and monoclonal antibodies
Chapter 24.1 kinase inhibitors and monoclonal antibodiesChapter 24.1 kinase inhibitors and monoclonal antibodies
Chapter 24.1 kinase inhibitors and monoclonal antibodies
 

Shock

  • 2. shock • tissue hypoperfusion that is insufficient to maintain normal aerobic metabolism • consists of inadequate tissue perfusion marked by decreased delivery of required metabolic substrates and inadequate removal of cellular waste products • the resultant cellular injury is initially reversible; if the hypoperfusion is severe enough and prolonged, the cellular injury becomes irriversible • the clinical manifestations are the result of: •stimulation of the sympathetic and neuro-endocrine stress responses • inadequate oxygen delivery • end-organ dysfunction
  • 3. patho-physiology of shock disruption host-microbial trauma equilibrium tissue hypoperfusion neurologic injury cellular hypoxia/ischemia hemorrhage acute heart failure shock
  • 4. neuro-endocrine response to hemorrhage • its goal is to maintain perfusion to the heart and brain , even at the expense of other organ systems • mechanisms include: • autonomic control of peripheral vascular tone and cardiac contractility • hormonal response to stress and volume depletion • local microcirculatory mechanisms that are organ specific and regulate regional blood flow afferent signals • loss of circulating blood volume • pain, hypoxemia, hypercarbia, acidosis, infection, changes in temperature, emotional arousalm, hypoglycemia • baroreceptors • within the atria of the heart which efferent signals are sensitive to changes in chambert- • cardio-vascular response pressure and wall stretch • hormonal response • aortic arch and carotid bodies • circulatory homeostasis • chemoreceptors in the aorta and carotid • microcirculatory respons bodies are sensitive to changes in O2 tension, H+ ion concentration, and carbon dioxide (CO2) levels • stimulation of the chemoreceptors results in vasodilation of the coronary arteries, slowing of the heart rate, and vasoconstriction of the splanchnic and skeletal circulation • a variety of protein and nonprotein mediators are produced at the site of injury as part of the inflammatory response, and they act as afferent impulses to induce a host response
  • 5. cardio-vascular response • hemorrhage results in diminished venous return to the heart and decreased cardiac output • stimulation of sympathetic fibers innervating the heart leads to activation of beta1-adrenergic receptors that increase heart rate and contractility • sympathetic stimulation of the peripheral circulation via the activation of alpha1-adrenergic receptors on arterioles induces vasoconstriction and causes a compensatory increase in systemic vascular resistance and blood pressure • sympathetic stimulation also induces constriction of venous vessels, decreasing the capacitance of the circulatory system and accelerating blood return to the central circulation
  • 6. hormonal response • shock hypothalamus (CRH) pituitary gland (ACTH) adrenal cortex (cortisol) • cortisol stimulates gluconeogenesis and insulin resistance, resulting in hyperglycemia • cortisol stimulates muscle cell protein breakdown and lipolysis to provide substrates for hepatic gluconeogenesis • cortisol causes retention of sodium and water by the nephrons of the kidneys • renin-angiotensin system is activated in shock • decreased renal artery perfusion, beta-adrenergic stimulation, and increased renal tubular sodium concentration cause the release of renin from the juxtaglomerular cells • decreased renal •release of renin • renin catalyzes the • angiotensin I has no significant functional artery perfusion from the conversion of activity • beta-adrenergic juxtaglomerular angiotensinogen • angiotensin II stimulation cells (produced by the • a potent vasoconstrictor of both • increased renal liver) to angiotensin splanchnic and peripheral vascular tubular sodium I, which is then beds concentration converted to • stimulates the secretion of cause the release angiotensin II by aldosterone, ACTH, and antidiuretic of renin from the angiotensin- hormone (ADH) juxtaglomerular converting enzyme • aldosterone acts on the cells (ACE) produced in nephron to promote the lung reabsorption of sodium water. • potassium and hydrogen ions are lost in the urine in exchange for sodium.
  • 7. • epinephrine • hypovolemia • angiotensin II • pain • changes in circulating • hyperglycemia blood volume sensed by baroreceptors and left • pituitary gland releases increase the atrial stretch receptors vasopressin or ADH release of ADH • increased plasma osmolality detected by hypothalamic osmoreceptors • ADH acts: • on the distal tubule and collecting duct of the nephron to increase water permeability, decrease water and sodium losses, and preserve intravascular volume • as a potent mesenteric vasoconstrictor, shunting circulating blood away from the splanchnic organs during hypovolemia • this may contribute to intestinal ischemia and predispose to intestinal mucosal barrier dysfunction in shock states • increases hepatic gluconeogenesis and increases hepatic glycolysis
  • 8. Microcirculation • the microvascular bed is innervated by the sympathetic nervous system and has a profound effect on the larger arterioles • other vasoactive proteins including: • following hemorrhage • vasopressin larger arterioles • angiotensin II vasoconstrict; small • endothelin-1 distal arterioles vasodilate • also lead to vasoconstriction to limit organ perfusion to organs such as skin, skeletal muscle, kidneys, and the GI tract to preserve perfusion of the myocardium and CNS • flow in the capillary bed often is heterogeneous in shock states, which likely is secondary to multiple local mechanisms, including endothelial cell swelling, dysfunction, and activation marked by the recruitment of leukocytes • failure of the integrity of • decreased capillary hydrostatic the endothelium of the pressure secondary to changes in microcirculation and blood flow and increased cellular development of capillary uptake of fluid leak, intracellular swelling, and the development of an extracellular fluid deficit • intracellular swelling is multifactorial, but dysfunction of energy-dependent mechanisms, such as active transport by the sodium-potassium pump contributes to loss of membrane integrity.
  • 9. metabolic effects • cellular metabolism is based primarily on the hydrolysis of adenosine triphosphate (ATP) • majority of ATP is generated in our bodies through aerobic metabolism in the process of oxidative phosphorylation in the mitochondria • dependent on the availability of O2 as a final electron acceptor in the electron transport chain • when oxidative phosphorylation is insufficient, the cells shift to anaerobic metabolism and glycolysis to • O2 tension within a cell decreases, generate ATP there is a decrease in oxidative • this occurs via the breakdown of cellular phosphorylation, and the glycogen stores to pyruvate generation of ATP slows • under hypoxic conditions in anaerobic metabolism, pyruvate is converted into lactate, leading to an intracellular metabolic acidosis • depletion of ATP potentially influences all ATP-dependent cellular processes: • decreased intracellular pH also influences vital cellular functions such as: • maintenance of cellular • normal enzyme activity membrane potential • cell membrane ion exchange • synthesis of enzymes and • cellular metabolic signaling proteins • acidosis leads to changes in calcium metabolism and calcium • cell signaling signaling • DNA repair mechanisms
  • 10. immune and inflammatory responses • a well regulated complex set of interactions between circulating soluble factors and cells that can arise in response to trauma, infection, ischemia, toxic, or autoimmune stimuli • direct tissue injury or infection • activation of the active inflammatory • intracellular products from damaged and • pattern recognition receptors (PRRs) - cell surface and immune responses by the release of injured cells can have paracrine and • Toll-like receptors (TLRs) bioactive peptides by neurons in endocrine-like effects on distant tissues to • receptor for advanced glycation end response to pain and the release of activate the inflammatory and immune products intracellular molecules by broken responses – DANGER SIGNALING cells, such as heat shock HYPOTHESIS • initiation of the repair process and the proteins, mitochondrial • endogenous molecules (damage mobilization of antimicrobial defenses at the peptides, heparan sulfate, high mobility associated molecular patterns site of tissue disruption group box 1, and RNA {DAMP}) are capable of signaling • leads to intracellular signaling and release of the presence of danger to cellular products including cytokines surrounding cells and tissues • DAMP: • tissue-based macrophages or mast cells act as • Hyaluronan oligomers sentinel responders, releasing histamines, • Heparan sulfate eicosanoids, tryptases, and cytokines • Extra domain A of fibronectin • Heat shock proteins 60, 70, • Gp96 •Surfactant Protein A - Defensin 2 • Fibrinogen • Biglycan • High mobility group box 1 • Uric acid • Interleukin-1 S-100s Nucleolin
  • 11.
  • 12. Hypovolemic/Hemorrhagic Shock • most common cause of shock in the surgical or trauma patient is loss of circulating volume from hemorrhage • acute blood loss • decreased baroreceptor • decreased inhibition of stimulation from stretch vasoconstrictor centers in the brain receptors in the large arteries stem, increased chemoreceptor stimulation of vasomotor centers, and diminished output from atrial • increase vasoconstriction stretch receptors and peripheral arterial resistance • epinephrine and norepinephrine • induces sympathetic stimulation release, activation of the renin- angiotensin cascade, and increased vasopressin release
  • 13. Classification of Hemorrhage Class Parameter I II III IV Blood loss (mL) <750 750–1500 1500–2000 >2000 Blood loss (%) <15 15–30 30–40 >40 Heart rate (bpm) <100 >100 >120 >140 Blood pressure Normal Orthostatic Hypotension Severe hypotension CNS symptoms Normal anxious confused obtunded, mild tachycardia hypotension, immediately life tachypnea marked threatening, and tachycardia [i.e., generally pulse greater requires than 110 to 120 operative beats per control of minute (bpm)] bleeding
  • 14. • the appropriate priorities in patients with hemorrhagic shock are: • secure the airway • control the source of blood loss • IV volume resuscitation • patients who fail to respond to initial resuscitative efforts should be assumed to have ongoing active hemorrhage from large vessels and require prompt operative intervention • diagnostic and therapeutic laparotomy or thoracotomy • patients who respond to initial resuscitative effort but then deteriorate hemodynamically frequently have injuries that require operative intervention • patients who fail to respond to resuscitative efforts despite adequate control of ongoing hemorrhage • have ongoing fluid requirements despite adequate control of hemorrhage • have persistent hypotension despite restoration of intravascular volume necessitating vasopressor support • exhibit a futile cycle of uncorrectable hypothermia, hypoperfusion, acidosis, and coagulopathy that cannot be interrupted despite maximum therapy • these patients have deteriorated to decompensated or irreversible shock with peripheral vasodilation and resistance to vasopressor infusion • mortality is inevitable once the patient manifests shock in its terminal stages • transfusion of packed red blood cells and other blood products is essential in the treatment of patients in hemorrhagic shock • current recommendations in stable ICU patients aim for a target hemoglobin of 7 to 9 g/dL • fresh frozen plasma (FFP) should also be transfused in patients with massive bleeding or bleeding with increases in prothrombin or activated partial thromboplastin times 1.5 times greater than control • additional resuscitative adjuncts in patients with hemorrhagic shock include minimization of heat loss and maintaining normothermia • development of hypothermia in the bleeding patient is associated with acidosis, hypotension, and coagulopathy • hypothermia in bleeding trauma patients is an independent risk factor for bleeding and death
  • 15. Septic Shock (Vasodilatory Shock) • vasodilatory shock is the result of dysfunction of the endothelium and vasculature secondary to circulating inflammatory mediators and cells or as a response to prolonged and severe hypoperfusion • hypotension results from failure of the vascular smooth muscle to constrict appropriately • characterized by peripheral vasodilation with resultant hypotension and resistance to treatment with vasopressors • the most frequently encountered form of vasodilatory shock is septic shock • other causes include: • hypoxic lactic acidosis • carbon monoxide poisoning • decompensated and irreversible hemorrhagic shock • terminal cardiogenic shock • postcardiotomy shock • vasodilatory shock seems to represent the final common pathway for profound and prolonged shock of any etiology • in addition to fever, tachycardia, and tachypnea, signs of hypoperfusion such as confusion, malaise, oliguria, or hypotension may be present • these should prompt an aggressive search for infection, including a thorough physical examination, inspection of all wounds, evaluation of intravascular catheters or other foreign bodies, obtaining appropriate cultures, and adjunctive imaging studies, as needed
  • 16. • evaluation of the patient in septic shock begins with an assessment of the adequacy of their airway and ventilation • severely obtunded patients and patients whose work of breathing is excessive require intubation and ventilation to prevent respiratory collapse • vasodilation and decrease in total peripheral resistance may produce hypotension • fluid resuscitation and restoration of circulatory volume with balanced salt solutions is essential • empiric antibiotics must be chosen carefully based on the most likely pathogens (gram-negative rods, gram- positive cocci, and anaerobes) because the portal of entry of the offending organism and its identity may not be evident until culture data return or imaging studies are completed • knowledge of the bacteriologic profile of infections in an individual unit can be obtained from most hospital infection control departments and will suggest potential responsible organisms • antibiotics should be tailored to cover the responsible organisms once culture data are available, and if appropriate, the spectrum of coverage narrowed • after first-line therapy of the septic patient with antibiotics, IV fluids, and intubation if necessary, vasopressors may be necessary to treat patients with septic shock • catecholamines are the vasopressors used most often • hyperglycemia and insulin resistance are typical in critically ill and septic patients, including patients without underlying diabetes mellitus